Development Level

Tbio 3 | 10,625
Tchem 1 | 1,890

Disease

Cancer 4 | 2,346
Adenoma 3 | 165
Breast cancer 3 | 3,094
Colorectal Neoplasms 3 | 217
Mammary Neoplasms 3 | 410
Neoplastic Cell Transformation 3 | 81
ductal carcinoma in situ 3 | 1,745
ovarian cancer 3 | 8,484
pilocytic astrocytoma 3 | 3,086
psoriasis 3 | 6,685
Adenoid Cystic Carcinoma 2 | 99
Animal Mammary Neoplasms 2 | 136
Bladder Neoplasm 2 | 109
Carcinoma 2 | 2,147
Chronic Lymphocytic Leukemia 2 | 242
Helicobacter Infections 2 | 5
Intestinal benign neoplasm 2 | 11
Kidney disease 2 | 396
Lung Neoplasms 2 | 171
Mammary Neoplasms, Experimental 2 | 150
Multiple myeloma 2 | 1,327
Myocardial Ischemia 2 | 169
Precancerous Conditions 2 | 69
Prostatic Neoplasms 2 | 471
Salivary Gland Neoplasms 2 | 45
Stomach Neoplasms 2 | 282
atypical teratoid/rhabdoid tumor 2 | 1,095
esophageal adenocarcinoma 2 | 737
group 4 medulloblastoma 2 | 1,875
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
invasive ductal carcinoma 2 | 2,950
lung cancer 2 | 4,466
lung carcinoma 2 | 2,844
malignant mesothelioma 2 | 3,162
medulloblastoma, large-cell 2 | 6,234
nasopharyngeal carcinoma 2 | 1,056
non-small cell lung cancer 2 | 2,798
osteosarcoma 2 | 7,933
pancreatic cancer 2 | 2,300
primitive neuroectodermal tumor 2 | 3,031
ulcerative colitis 2 | 2,087
Anemia 1 | 252
Barrett's esophagus 1 | 183
Beta thalassemia 1 | 19
Carcinoma, Transitional Cell 1 | 31
Colonic Neoplasms 1 | 126
Colorectal Cancer 1 | 47
Disease Progression 1 | 125
Endometrial Neoplasms 1 | 50
Endometrial carcinoma 1 | 18
Esophageal Neoplasms 1 | 67
Familial adenomatous polyposis 1 | 31
Gastritis 1 | 44
Gastrointestinal system disease 1 | 50
Glioma 1 | 65
Hemangiosarcoma 1 | 18
Human immunodeficiency virus infectious disease 1 | 92
Hyperparathyroidism 1 | 43
Hypersensitivity reaction type II disease 1 | 235
Hypotrichosis 1 | 29
Inflammation 1 | 109
Inflammatory bowel disease 1 | 142
Iron Metabolism Disorders 1 | 5
Iron metabolism disease 1 | 17
Keratosis 1 | 34
Kidney Neoplasm 1 | 27
Kidney cancer 1 | 118
Leukemia 1 | 88
Listeriosis 1 | 17
Liver Neoplasms, Experimental 1 | 48
Liver carcinoma 1 | 217
Lobular neoplasia 1 | 15
Lung disease 1 | 132
Lymphoma, Non-Hodgkin 1 | 22
Malaria 1 | 140
Mesothelioma 1 | 40
Myocardial Reperfusion Injury 1 | 34
Neoplasm Invasiveness 1 | 127
Neoplasm Metastasis 1 | 138
Neoplasms, Experimental 1 | 33
Neoplastic Syndromes, Hereditary 1 | 48
Nerve Degeneration 1 | 73
Neurodegenerative disease 1 | 383
Pancreatic Neoplasm 1 | 79
Papilloma 1 | 27
Peripheral vascular disease 1 | 90
Polycystic Ovary Syndrome 1 | 332
Primary hyperparathyroidism 1 | 4
Prostate cancer 1 | 172
Prostatic Intraepithelial Neoplasias 1 | 11
Severe Combined Immunodeficiency 1 | 46
Squamous cell carcinoma 1 | 94
Squamous cell carcinoma of esophagus 1 | 82
Thalassemia 1 | 46
Thyroid Neoplasm 1 | 33
Urologic Neoplasms 1 | 7
Usher syndrome 1 | 34
Von Hippel-Lindau Syndrome 1 | 2
ovarian neoplasm 1 | 97
type II diabetes mellitus and post-ischemic heart failure 1 | 89

Tissue

Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Endocrine System 4 | 18,512
Female tissues 4 | 18,647
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Nervous System 4 | 18,561
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444

Target Family

Non-IDG 4 | 11,971

Grant Application

5R01DK073897-03 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Transferrin receptor protein 1 TFRC Tbio Non-IDG -3.39868 2437.0 1167
G1/S-specific cyclin-D1 CCND1 Tchem Non-IDG -3.77851 5447.1 1111
Cadherin-17 CDH17 Tbio Non-IDG -3.34474 1918.4 224
Cadherin-1 CDH1 Tbio Non-IDG -3.78431 5832.3 1347